ORCHARD THERAPEUTICS PLC Marketable Securities
ORCHARD THERAPEUTICS PLC had Marketable Securities of $101.94 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2023-11-13
- 2023-09-30: Marketable Securities $101.94M.
- 2023-06-30: Marketable Securities $112.47M.
- 2023-03-31: Marketable Securities $84.83M.
- 2022-12-31: Marketable Securities $75.33M.
| Period end | Marketable Securities |
|---|---|
| 2023-09-30 | $101.94M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $112.47M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $84.83M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $75.33M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $65.80M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $117.42M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $138.24M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $164.19M 10-K · filed 2023-03-14 |
| 2021-09-30 | $179.82M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $169.38M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $219.54M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $136.81M 10-K · filed 2022-03-30 |
| 2020-09-30 | $160.18M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $187.48M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $236.77M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $305.94M 10-K · filed 2021-03-02 |
| 2019-09-30 | $330.68M 6-K · filed 2019-11-07 |
| 2019-06-30 | $286.75M 6-K · filed 2019-08-08 |